Adma Biologics Inc’s recent filing unveils that its Director Grossman Jerrold B unloaded Company’s shares for reported $0.21 million on Jun 09 ’25. In the deal valued at $21.31 per share,10,000 shares were sold. As a result of this transaction, Grossman Jerrold B now holds 478,194 shares worth roughly $9.98 million.
Then, Grossman Jerrold B bought 10,000 shares, generating $206,100 in total proceeds.
Before that, Lawrence P Guiheen Rev Tr DTD bought 20,000 shares. Adma Biologics Inc shares valued at $415,000 were divested by the Director at a price of $20.75 per share.
A number of analysts have revised their coverage, including Mizuho’s analysts, who began to cover the stock in mid October with a ‘”a Buy”‘ rating. Raymond James also remained covering ADMA and has increased its forecast on November 11, 2021 with a “Strong buy” recommendation from previously “an Outperform” rating. Cantor Fitzgerald started covering the stock on November 09, 2021. It rated ADMA as “an Overweight”.
Price Performance Review of ADMA
On Tuesday, Adma Biologics Inc [NASDAQ:ADMA] saw its stock fall -0.05% to $20.86. Over the last five days, the stock has gained 1.96%. Adma Biologics Inc shares have risen nearly 21.63% since the year began. Nevertheless, the stocks have risen 97.16% over the past one year.
How much short interest is there in Adma Biologics Inc?
A steep rise in short interest was recorded in Adma Biologics Inc stocks on 2025-05-15, growing by 77071.0 shares to a total of 13.33 million shares. Yahoo Finance data shows the prior-month short interest on 2025-04-15 was 13.26 million shares. There was a rise of 0.58%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on June 04, 2019 when Jefferies began covering the stock and recommended ‘”a Buy”‘ rating along with a $8 price target.
